Parsons Capital Management Inc Relmada Therapeutics, Inc. Transaction History

Parsons Capital Management Inc

$1.55 Billion
Q3 2024

A detailed history of Parsons Capital Management Inc transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Parsons Capital Management Inc holds 1,002,695 shares of RLMD stock, worth $2.99 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

1,002,695

Previous 975,945 2.74%

Holding current value

$2.99 Million

Previous $2.93 Million 10.97%

% of portfolio

0.21%

Previous 0.2%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$2.3 - $4.36 $61,524 - $116,630	26,750 Added 2.74%	1,002,695 $3.25 Million
Q2 2024 Jul 19, 2024	BUY	$2.93 - $4.94 $7,105 - $11,979	2,425 Added 0.25%	975,945 $2.93 Million
Q1 2024 Apr 22, 2024	BUY	$3.1 - $6.8 $73,404 - $161,017	23,679 Added 2.49%	973,520 $4.53 Million
Q4 2023 Jan 22, 2024	SELL	$2.45 - $4.22 $59,390 - $102,297	-24,241 Reduced 2.49%	949,841 $3.93 Million
Q3 2023 Nov 06, 2023	BUY	$2.48 - $3.79 $249,909 - $381,918	100,770 Added 11.54%	974,082 $2.92 Million
Q2 2023 Aug 04, 2023	BUY	$2.22 - $3.54 $335,544 - $535,056	151,146 Added 20.93%	873,312 $2.15 Million
Q1 2023 Apr 17, 2023	BUY	$2.24 - $4.76 $506,042 - $1.08 Million	225,912 Added 45.52%	722,166 $1.63 Million
Q4 2022 Feb 13, 2023	SELL	$2.17 - $35.84 $16,376 - $270,484	-7,547 Reduced 1.5%	496,254 $1.73 Million
Q3 2022 Oct 26, 2022	BUY	$18.3 - $37.02 $457 - $925	25 Added 0.0%	503,801 $18.7 Million
Q2 2022 Jul 29, 2022	BUY	$16.5 - $30.34 $11,550 - $21,238	700 Added 0.14%	503,776 $9.57 Million
Q1 2022 May 02, 2022	SELL	$16.72 - $26.99 $5,617 - $9,068	-336 Reduced 0.07%	503,076 $13.6 Million
Q4 2021 Feb 07, 2022	BUY	$16.93 - $26.82 $515,315 - $816,347	30,438 Added 6.44%	503,412 $11.3 Million
Q3 2021 Nov 09, 2021	BUY	$21.86 - $34.77 $493,205 - $784,480	22,562 Added 5.01%	472,974 $12.4 Million
Q2 2021 Aug 03, 2021	SELL	$29.55 - $39.15 $29,550 - $39,150	-1,000 Reduced 0.22%	450,412 $14.4 Million
Q1 2021 Apr 28, 2021	SELL	$31.52 - $39.28 $6,304 - $7,856	-200 Reduced 0.04%	451,412 $15.9 Million
Q4 2020 Feb 08, 2021	SELL	$29.88 - $39.8 $105,327 - $140,295	-3,525 Reduced 0.77%	451,612 $14.5 Million
Q3 2020 Oct 29, 2020	BUY	$34.42 - $43.78 $36,141 - $45,969	1,050 Added 0.23%	455,137 $17.1 Million
Q2 2020 Aug 10, 2020	BUY	$31.59 - $49.98 $900,694 - $1.43 Million	28,512 Added 6.7%	454,087 $20.3 Million
Q1 2020 May 05, 2020	BUY	$23.78 - $50.12 $1.39 Million - $2.94 Million	58,642 Added 15.98%	425,575 $14.5 Million
Q4 2019 Feb 03, 2020	BUY	$10.1 - $47.18 $3.71 Million - $17.3 Million	366,933 New	366,933 $14.3 Million

Others Institutions Holding RLMD

# of Institutions

Shares Held

12.3M

Call Options Held

229K

Put Options Held

138K

View Full List

About RELMADA THERAPEUTICS, INC.

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $85.3M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

More about RLMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parsons Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Parsons Capital Management Inc with notifications on news.

Account

Parsons Capital Management Inc Relmada Therapeutics, Inc. Transaction History